本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

IGM Biosciences

1.13
+0.0000
盤後1.11-0.0200-1.77%19:47 EDT
成交量:22.64萬
成交額:25.74萬
市值:6,754.62萬
市盈率:-0.35
高:1.19
開:1.12
低:1.11
收:1.13
資料載入中...
2024/07/02

SEC問詢函

Form CORRESP - Correspondence
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/17

重要事件披露

Form 8-K - Current report
2024/03/28

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/07

重要事件披露

Form 8-K - Current report
2024/03/07

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/09

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/16

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/08

重要事件披露

Form 8-K - Current report